Tissue factor pathway inhibitor

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
PDB rendering based on 1adz.
Identifiers
Symbol(s) TFPI; TFI; EPI; LACI
External IDs OMIM: 152310 MGI1095418 Homologene4579
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 7035 21788
Ensembl ENSG00000003436 ENSMUSG00000027082
Uniprot P10646 O54819
Refseq NM_001032281 (mRNA)
NP_001027452 (protein)
NM_011576 (mRNA)
NP_035706 (protein)
Location Chr 2: 188.04 - 188.13 Mb Chr 2: 84.23 - 84.28 Mb
Pubmed search [1] [2]

WikiDoc Resources for

Tissue factor pathway inhibitor

Articles

Most recent articles on Tissue factor pathway inhibitor

Most cited articles on Tissue factor pathway inhibitor

Review articles on Tissue factor pathway inhibitor

Articles on Tissue factor pathway inhibitor in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Tissue factor pathway inhibitor

Images of Tissue factor pathway inhibitor

Photos of Tissue factor pathway inhibitor

Podcasts & MP3s on Tissue factor pathway inhibitor

Videos on Tissue factor pathway inhibitor

Evidence Based Medicine

Cochrane Collaboration on Tissue factor pathway inhibitor

Bandolier on Tissue factor pathway inhibitor

TRIP on Tissue factor pathway inhibitor

Clinical Trials

Ongoing Trials on Tissue factor pathway inhibitor at Clinical Trials.gov

Trial results on Tissue factor pathway inhibitor

Clinical Trials on Tissue factor pathway inhibitor at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Tissue factor pathway inhibitor

NICE Guidance on Tissue factor pathway inhibitor

NHS PRODIGY Guidance

FDA on Tissue factor pathway inhibitor

CDC on Tissue factor pathway inhibitor

Books

Books on Tissue factor pathway inhibitor

News

Tissue factor pathway inhibitor in the news

Be alerted to news on Tissue factor pathway inhibitor

News trends on Tissue factor pathway inhibitor

Commentary

Blogs on Tissue factor pathway inhibitor

Definitions

Definitions of Tissue factor pathway inhibitor

Patient Resources / Community

Patient resources on Tissue factor pathway inhibitor

Discussion groups on Tissue factor pathway inhibitor

Patient Handouts on Tissue factor pathway inhibitor

Directions to Hospitals Treating Tissue factor pathway inhibitor

Risk calculators and risk factors for Tissue factor pathway inhibitor

Healthcare Provider Resources

Symptoms of Tissue factor pathway inhibitor

Causes & Risk Factors for Tissue factor pathway inhibitor

Diagnostic studies for Tissue factor pathway inhibitor

Treatment of Tissue factor pathway inhibitor

Continuing Medical Education (CME)

CME Programs on Tissue factor pathway inhibitor

International

Tissue factor pathway inhibitor en Espanol

Tissue factor pathway inhibitor en Francais

Businness

Tissue factor pathway inhibitor in the Marketplace

Patents on Tissue factor pathway inhibitor

Experimental / Informatics

List of terms related to Tissue factor pathway inhibitor

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3] Phone:617-525-6884

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [4] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Tissue factor pathway inhibitor (or TFPI) is a single-chain polypeptide which can reversibly inhibit Factor Xa (Xa). While Xa is inhibited, the Xa-TFPI complex can subsequently also inhibit the FVIIa-TF complex. TFPI contributes significantly to the inhibition of Xa in vivo, despite being present at concentrations of only 2.5nM.

Genetics

The gene for TFPI is located on chromosome 2q31-q32.1, and has nine exons which span 70kb. The gene has not been completely sequenced yet. A similar gene, termed TFPI2, has been identified on chromosome 7q22; in addition to TFPI activity, its product also has retinal pigment epithelial cell growth-promoting properties.

Protein structure

TFPI has a relative molecular mass of 34000 to 40000 depending on the degree of proteolysis of the C-terminal region.

See also

External links

References

Further reading

  • Broze GJ, Girard TJ, Novotny WF (1991). "Regulation of coagulation by a multivalent Kunitz-type inhibitor.". Biochemistry 29 (33): 7539-46. PMID 2271516.
  • McVey JH (2000). "Tissue factor pathway.". Baillieres Best Pract. Res. Clin. Haematol. 12 (3): 361-72. PMID 10856975.
  • Bajaj MS, Birktoft JJ, Steer SA, Bajaj SP (2002). "Structure and biology of tissue factor pathway inhibitor.". Thromb. Haemost. 86 (4): 959-72. PMID 11686353.
  • Witt I (2002). "[Tissue factor pathway inhibitor: biochemistry, molecular biology, physiology and physiopathology]". Hamostaseologie 22 (2): 30-5. doi:10.1267/Hamo02020071. PMID 12193974.
  • Lwaleed BA, Bass PS (2006). "Tissue factor pathway inhibitor: structure, biology and involvement in disease.". J. Pathol. 208 (3): 327-39. doi:10.1002/path.1871. PMID 16261634.
  • Van der Logt CP, Kluck PM, Wiegant J, et al. (1992). "Refined regional assignment of the human tissue factor pathway inhibitor (TFPI) gene to chromosome band 2q32 by non-isotopic in situ hybridization.". Hum. Genet. 89 (5): 577-8. PMID 1353057.
  • Higuchi DA, Wun TC, Likert KM, Broze GJ (1992). "The effect of leukocyte elastase on tissue factor pathway inhibitor.". Blood 79 (7): 1712-9. PMID 1558967.
  • van der Logt CP, Reitsma PH, Bertina RM (1991). "Intron-exon organization of the human gene coding for the lipoprotein-associated coagulation inhibitor: the factor Xa dependent inhibitor of the extrinsic pathway of coagulation.". Biochemistry 30 (6): 1571-7. PMID 1993173.
  • Girard TJ, Eddy R, Wesselschmidt RL, et al. (1991). "Structure of the human lipoprotein-associated coagulation inhibitor gene. Intro/exon gene organization and localization of the gene to chromosome 2.". J. Biol. Chem. 266 (8): 5036-41. PMID 2002045.
  • Wun TC, Kretzmer KK, Girard TJ, et al. (1988). "Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.". J. Biol. Chem. 263 (13): 6001-4. PMID 2452157.
  • Novotny WF, Girard TJ, Miletich JP, Broze GJ (1989). "Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma.". J. Biol. Chem. 264 (31): 18832-7. PMID 2553722.
  • Girard TJ, Warren LA, Novotny WF, et al. (1989). "Identification of the 1.4 kb and 4.0 kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein.". Thromb. Res. 55 (1): 37-50. PMID 2781520.
  • Girard TJ, Warren LA, Novotny WF, et al. (1989). "Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor.". Nature 338 (6215): 518-20. doi:10.1038/338518a0. PMID 2927510.
  • Broze GJ, Miletich JP (1987). "Characterization of the inhibition of tissue factor in serum.". Blood 69 (1): 150-5. PMID 3024756.
  • Broze GJ, Warren LA, Novotny WF, et al. (1988). "The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.". Blood 71 (2): 335-43. PMID 3422166.
  • Rao LV, Rapaport SI (1987). "Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation.". Blood 69 (2): 645-51. PMID 3492226.
  • Stubbs MT, Huber R, Bode W (1996). "Crystal structures of factor Xa specific inhibitors in complex with trypsin: structural grounds for inhibition of factor Xa and selectivity against thrombin.". FEBS Lett. 375 (1-2): 103-7. PMID 7498454.
  • Warshawsky I, Bu G, Mast A, et al. (1995). "The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo.". J. Clin. Invest. 95 (4): 1773-81. PMID 7706485.
  • Broze GJ, Lange GW, Duffin KL, MacPhail L (1995). "Heterogeneity of plasma tissue factor pathway inhibitor.". Blood Coagul. Fibrinolysis 5 (4): 551-9. PMID 7841311.
WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools